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Abstract: Nucleotide excision repair (NER) is a versatile DNA repair pathway which can be 
activated in response to a broad spectrum of UV-induced DNA damage, such as bulky adducts, 
including cyclobutane-pyrimidine dimers (CPDs) and 6–4 photoproducts (6–4PPs). Based on the 
genomic position of the lesion, two sub-pathways can be defined: (I) global genomic NER (GG-
NER), involved in the ablation of damage throughout the whole genome regardless of the 
transcription activity of the damaged DNA locus, and (II) transcription-coupled NER (TC-NER), 
activated at DNA regions where RNAPII-mediated transcription takes place. These processes are 
tightly regulated by coordinated mechanisms, including post-translational modifications (PTMs). 
The fine-tuning modulation of the balance between the proteins, responsible for PTMs, is essential 
to maintain genome integrity and to prevent tumorigenesis. In this review, apart from the other 
substantial PTMs (SUMOylation, PARylation) related to NER, we principally focus on reversible 
ubiquitylation, which involves E3 ubiquitin ligase and deubiquitylase (DUB) enzymes responsible 
for the spatiotemporally precise regulation of NER. 
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1. Introduction 
In eukaryotic cells exposed to UV-irradiation, two different modes of nucleotide excision repair 
(NER) are activated: (I) global genomic-nucleotide excision repair (GG-NER) and (II) transcription-
coupled-nucleotide excision repair (TC-NER), which is involved in the recognition of distorted DNA 
and determines both spatial and time-related preferences [1,2]. NER contributes to the elimination of 
helix-distorting lesions, including cyclobutane-pyrimidine dimers (CPDs), 6-4 photoproducts (6-
4PPs), and other bulky adducts; hence, it maintains genome stability. The complexity of NER 
pathways, the size and scaffold structure of the lesion, and the functions of the repair factors need to 
be orchestrated in a multi-stage process. The coordinated interactions of more than 30 proteins 
involved in NER are mainly controlled by various post-translational modifications (PTMs), including 
ubiquitylation, ADP-ribosylation (PARylation), and SUMOylation. 
Ubiquitylation is catalyzed by E1 activating, E2 conjugating, and E3 ligase enzymes [3]. During 
ubiquitylation, one or more ubiquitin molecule(s) (referred to as monoubiquitylation and 
polyubiquitylation, respectively) can be transferred to the target protein, and this process results in 
different outcomes regarding the type of ubiquitin linkage. For instance, in most cases, K48-linked 
polyubiquitylation leads to the proteasomal degradation of the target protein, while K63-linked 
chains take part in other cellular processes [4]. During ubiquitylation, it is essential to maintain the 
balance between the E3 ligases and deubiquitylases (DUBs) responsible for the removal of the 
ubiquityl groups. CRL4DDB2 and CRL4CSA (Cullin-RING ubiquitin ligase) E3 ligase complexes catalyze 
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the initial steps, determining the following downstream steps in GG-NER and TC-NER, respectively. 
In GG-NER, XPC (Xeroderma pigmentosum, complementation group C), which is one of the first 
sensors of DNA damage, can be either polyubiquitylated at K48-linked chains by CRL4DDB2 or at K63-
linked chains by RNF111 (Ring Finger Protein 111, also known as Arkadia), resulting in different 
outcomes. These sites can be deubiquitylated by UBP12 (Ubiquitin specific protease 12) and USP24 
(Ubiquitin specific peptidase 24) (at K48) as well as by USP7 (Ubiquitin specific peptidase 7) and 
OTUD4 (OTU deubiquitinase 4) (at K63). In TC-NER, CSB (Cockayne syndrome B protein), which 
traverses together with the RNAPII (RNA polymerase II), should be removed from the DNA by 
CRL4CSA- and BRCA1-BARD1 (Breast Cancer Type 1 Susceptibility Protein - BRCA1 Associated RING 
Domain 1)-mediated ubiquitylation-coupled proteasomal degradation to allow access for further 
repair proteins. However, as long as necessary, CSB is deubiquitylated by USP7 at these sites to 
remain recruited at the lesions. In certain cases, the elongating RNAPII (S2P RNAPII) should be 
removed from the damage site. This process involves E3 ligases, including BRCA1-BARD1, NEDD4 
(Neural Precursor Cell Expressed, Developmentally Down-Regulated 4), and Elongin A/B/C-Cul5-
RBX2 (RING-box protein 2) complexes [5–7]. These ubiquitylation steps can be reversed by UBP2 
(Ubiquitin specific protease 2) and UBP3 (Ubiquitin specific protease 3) [8]. 
PARylation is also a reversible PTM, which is catalyzed by poly(ADP-ribose) polymerases 
(PARPs), responsible for the formation of an ester bond between ADP-ribose and the carboxyl-group 
of acidic amino acids [9,10]. Among these enzymes, PARP-1 (Poly(ADP-ribose) polymerase 1) has 
been shown to be involved in both single- and double-strand break repair [11]. Interestingly, while 
the depletion of PARP-1 results in failure of DNA damage repair processes, it has a controversial 
effect on mitochondrial activity. However, less information has been ascertained about the negative 
impact of PARP-1 on mitochondrial biogenesis, which has to be further elucidated [12,13]. Moreover, 
since PARylation is a reversible process, PAR chains can be hydrolyzed by PAR glycohydrolase 
(PARG) [14]. 
SUMO enzymes are produced in the cells as inactive pro-enzymes and they are first activated 
by sentrin/small ubiquitin-like modifier-specific proteases (SENPs), which are also capable of 
catalyzing the reversal deSUMOylation process [15]. Similar to ubiquitylation, SUMO conjugation 
requires E1 activating, E2 conjugating, and E3 ligase enzymes. The concerted cooperation of these 
enzymes leads to the formation of an iso-peptide bond between the C-terminal glycine residue of 
SUMO and the lysine amino acid of the target protein [16]. In humans, four known SUMOs are 
present: SUMO-1, SUMO-2, SUMO-3, and SUMO-4. Additionally, it is important to note that RNF111, 
a SUMO-targeted ubiquitin ligase (STUbL), plays a pivotal role during NER by triggering important 
crosstalk between SUMOylation and ubiquitylation [17]. 
In this review we introduce the most important PTMs that play an essential role in NER, 
although we principally emphasize the regulatory role of ubiquitylation during GG-NER and TC-
NER. Furthermore, we highlight the opposing roles of these PTMs in the same target protein. In turn, 
the balance of these actions ensures the coordination of the repair pathway. These processes jointly 
contribute to the preservation of genome integrity, which may prevent cancerous malformations. 
2. Ubiquitylation-Mediated Processes During Nucleotide Excision Repair 
2.1. Global Genomic-Nucleotide Excision Repair 
In the first step of GG-NER, XPC in the complex with RAD23B (RAD23 Homolog B) and CETN2 
(Centrin 2) can directly bind to the opposite DNA strand, where helix-distorting lesions have 
accumulated [18,19]. In contrast, CPDs slightly distort the DNA; therefore, XPC is recruited to such 
damaged sites only after the binding of the UV-DDB (UV-damaged DNA-binding protein) complex 
[20]. This complex comprises DDB1 (DNA-Damage-Binding Protein 1) and DDB2 (DNA-Damage-
Binding Protein 2), which then forms a larger complex (CRL4DDB2) with CRL composed of CUL4A 
(Cullin 4A) E3 ubiquitin ligase and RBX1/ROC1 (RING-box protein 1/RING subunit of SCF) E2 
ubiquitin-conjugating enzyme [21]. DDB1 ensures the linkage between DDB2 and the CRL complex, 
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while DDB2, which is the DNA-binding component, is required for recruiting XPC to CPDs by 
facilitating the looping of the broken DNA strand [22] (Figure 1A). 
This process is regulated by PTMs of DDB2 as follows: (I) SUMOylation at K309 by SUMO-1 
(Small ubiquitin-related modifier 1), (II) PARylation by PARP-1 and (III) ubiquitylation by UV-DDB 
itself [23,24]. SUMOylation of DDB2 ensures the binding of XPC to the kinked DNA region [23] 
(Figure 1A,B). However, PARylation and ubiquitylation exert opposite effects on DDB2; they modify 
K1-7 located within the first 40 N-terminal amino acid residues as follows: (I) PARylation results in 
the stabilization of the protein and promotes the recruitment of ALC1 (Amplified in liver cancer 1) 
chromatin remodeler; (II) K48-linked polyubiquitylation leads to its VCP/p97 (Valosin-containing 
protein)-mediated proteasomal degradation [24,25] (Figure 1A,C). USP24 DUB is capable of 
removing the ubiquityl groups from DDB2 and therefore contributes to the fine-tuning of GG-NER 
[26] (Figure 1B). 
Activation of the CRL4DDB2 complex requires its interaction with NEDD8 (Neural Precursor Cell 
Expressed, Developmentally Down-Regulated 8). Under physiological conditions, the binding of the 
COP9 (Constitutive photomorphogenesis 9) signalosome (CSN) catalyzes the removal of NEDD8 
from CUL4 to inactivate CRL4DDB2 [27]. After UV-irradiation, COP9 dissociates from the complex, 
allowing its neddylation and subsequent activation [21] (Figure 1A). Additionally, COP9 also has 
DUB activity and in fission yeast, it can recruit UBP12 to the CRL4DDB2 complex by which K48-linked 
ubiquityl groups are removed from the complex [28] (Figure 1B). 
As noted above, RAD23B plays an indispensable role in facilitating the binding of XPC to helix-
distorting lesions generated by UV-irradiation. Next, interaction ceases between the two proteins and 
simultaneously, XPC is ubiquitylated [29]. However, polyubiquitylation of XPC can result in different 
outcomes depending on the type of ubiquitin linkage (K48 or K63). Moreover, DDB2 and RNF111 are 
essential for GG-NER, although they affect XPC differently: (I) DDB2 presumably catalyzes the K48-
linked polyubiquitylation of XPC, and thus leads to its increased DNA-binding affinity; (II) while 
UBC13 (Ubiquitin-conjugating enzyme E2 13)/RNF111 mediates the non-proteolytic K63-linked 
polyubiquitylation of XPC, which results in the dissociation of XPC from DNA [17,30,31]. This step 
is reversible, since human DUB enzymes, USP7 and OTUD4 have been shown to catalyze the removal 
of ubiquityl groups from XPC probably by trimming K48-linked ubiquitin chains to permit RNF111-
related K63-linked polyubiquitylation of XPC at the same site (Figure 1B,C) [32,33]. This reaction 
removes XPC from the DNA and is therefore crucial for the later recruitment of XPF-ERCC1 
(Xeroderma pigmentosum, complementation group F - Excision Repair Cross-Complementation 
Group 1) and XPG (Xeroderma pigmentosum, complementation group G) to the appropriate position 
[34]. Although the removal of these polyubiquitin chains by USP7 leads to the unmodified state of 
XPC, it does not contribute to its proteasomal degradation but rather facilitates the recycling of the 
protein. In contrast, in the absence of USP7, XPC is targeted for VCP/p97-mediated proteasomal 
degradation [32] (Figure 1B).  
CRL4DDB2 can ubiquitylate H3 and H4 histones as well as H2A at its K119/K120 residues at 
damaged DNA sites. This leads to chromatin decondensation and gives NER factors access to the 
damaged site [35–37]. CRL4DDB2 catalyzes the K48-linked polyubiquitylation of these histones as well 
[22]. Furthermore, an additional E3 ligase complex, UV-RING1B (UV-Ring Finger Protein 1), 
specifically ubiquitylates H2A at K119. This results in the recruitment of ZRF1 (Zuotin-related factor 
1) and then leads to the reassembly of several multiprotein complexes [38–40] (Figure 1B). Although 
the deubiquitylation events on H2A have not yet been entirely clarified, it has been recently shown 
that USP51 (Ubiquitin specific peptidase 51) plays an essential role in deubiquitylation at K13–15 
residues of H2A [41] (Figure 1C). 
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Figure 1. Global genomic-nucleotide excision repair (A) XPC (Xeroderma pigmentosum, 
complementation group C), complexed with CETN2 (Centrin 2) and RAD23B (RAD23 Homolog B), 
binds to the opposite strand of helix-distorted lesions. In contrast, for CPDs (cyclobutane-pyrimidine 
dimers), XPC only binds to the damaged regions after the recruitment of the DDB1-DDB2 (DNA-
Damage-Binding Protein 1 - DNA-Damage-Binding Protein 2) complex, which then forms a larger 
complex (CRL4DDB2) with CUL4A (Cullin 4A) and ROC1 (RING-box protein 1/RING subunit of SCF). 
SUMO-1 (Small ubiquitin-related modifier 1) and PARP-1 (Poly(ADP-ribose) polymerase 1) catalyze 
the SUMOylation and PARylation of DDB2 at K309 and at K1-7, respectively. CRL4DDB2 activation 
requires the binding of NEDD8 (Neural Precursor Cell Expressed, Developmentally Down-Regulated 
8). However, under physiological conditions, COP9 (Constitutive photomorphogenesis 9) replaces 
NEDD8, leading to the inactivation of the complex. (B) Following DNA-binding, RAD23B dissociates 
from XPC and at the same time, XPC is polyubiquitylated. CUL4A can differentially affect DDB2 and 
XPC, although it catalyzes the K48-linked polyubiquitylation of both proteins. UBP12 (Ubiquitin 
specific protease 12) (recruited by COP9) and USP24 (Ubiquitin specific peptidase 24) remove the 
ubiquityl groups from DDB2. The CRL4DDB2 complex catalyzes the K48-linked polyubiquitylation of 
H3, H4, and H2A at K119/120, while UV-RING1B (UV-Ring Finger Protein 1) polyubiquitylates H2A 
at K119. OTUD4 (OTU deubiquitinase 4) and USP7 (Ubiquitin specific peptidase 7) participate in the 
removal of K48-linked ubiquityl groups from XPC. According to the ubiquitylation state of XPC, it 
can be either recycled or degraded in the proteasome. (C) USP51 (Ubiquitin specific peptidase 51) 
removes the ubiquityl groups from H2A K13/15. RNF111 (Ring Finger Protein 111, also known as 
Arkadia)-UBC13 (Ubiquitin-conjugating enzyme E2 13) catalyzes the K63-linked non-proteolytic 
polyubiquitylation of XPC. The K48-linked polyubiquitylation of DDB2 results in its dissociation from 
the CRL4DDB2 complex and its subsequent VCP/p97 (Valosin-containing protein)-mediated 
proteasomal degradation. Chromatin structural changes (from compacted (A) to a more relaxed form 
(B,C)) are represented in rectangles. 
2.2. Transcription-Coupled-Nucleotide Excision Repair 
One of the most tenacious activation signals for TC-NER is stalled S2P RNAPII, which covers an 
approximately 30 nucleotide DNA region upstream of the damaged site, preventing proper access of 
repair proteins to the lesion. Under physiological conditions, CSB interacts with the S2P RNAPII, and 
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this binding is further enhanced following UV-induced DNA damage. The ATP-dependent 
chromatin remodeling activity of CSB can be stimulated by the binding of NAP1L1 (Nucleosome 
assembly protein 1-like 1) and NAP1L4 (Nucleosome assembly protein 1-like 4) histone chaperones 
to CSB [42]. Subsequent recruitment of CSB to bulky lesions results in DNA bending and generates a 
more favorable conformation to which downstream repair factors can bind [43] (Figure 2A). In 
addition, CSB and CSA (Cockayne syndrome A protein) jointly contribute to the recruitment of 
factors involved in chromatin remodeling, such as the nucleosome binding protein HMGN1 (High-
Mobility Group Nucleosome Binding 1), p300 histone acetyl-transferase and the pre-mRNA splicing 
involved protein XAB2 (XPA Binding Protein 2) [43]. 
Since both CSA and DDB2 (involved in TC-NER and in GG-NER, respectively) are part of the 
DCAF (DDB1- and CUL4-associated factors) complex, both can form a complex with CUL4A E3 
ubiquitin ligase (CRL4CSA and CRL4DDB2, respectively) [21]. The ubiquitin ligase activity of CRL4CSA is 
also coordinated by the binding of COP9: (I) under physiological conditions, it strongly inhibits the 
ligase activity of CRL4CSA, (II) in response to DNA damage, it is released from CRL4CSA and thus 
promotes the E3 ligase activity of the complex [21,44]. In contrast to CRL4DDB2, COP9 does not 
dissociate from the CRL4CSA complex immediately after UV-irradiation [21] (Figure 2B). 
To promote the access of NER factors to the lesion, in most cases, RNAPII needs to be 
translocated from the site of DNA damage. In this process, a key function is attributed to CSB, the 
presence of which at the RNAPII-stalled region is regulated by UVSSA (UV-stimulated scaffold 
protein A) and CSA E3 ligase as well as USP7 DUB. CSA and UVSSA have opposing effects on CSB: 
(I) CSA (through the CRL4 complex) ubiquitylates CSB, and contributes to its removal through its 
ubiquitin-binding domain (UBD), (II) UVSSA stabilizes CSB by recruiting USP7. In addition, BRCA1-
BARD1 is also involved in the ubiquitin-mediated removal of CSB [5] (Figure 2B). Dissociation of 
CSB is a crucial step in lesion removal, since as long as CSB is present at the damage site, the incision 
step cannot be fulfilled [45] (Figure 2D). In contrast, it has been demonstrated that CSB can only be 
ubiquitylated when the repair process has been completed, which facilitates transcription restart [44]. 
The p62 subunit of TFIIH binds to DNA through UVSSA, presumably at the same site occupied 
by USP7 [46,47]. Consequently, USP7 dissociates from UVSSA, leading to the degradation of CSB 
through a ubiquitin-dependent proteasomal manner, promoting the further incision steps of TC-NER 
[47,48] (Figure 2C,D). Polyubiquitylation of UVSSA at K414 prevents its binding to USP7 and marks 
it for proteasomal degradation resulting in the malfunction of TC-NER [48,49]. 
The fate of RNAPII varies according to the type of DNA damage: (I) lesion bypass (Figure 2A), 
(II) backtracking (Figure 2D), (III) dissociation from DNA (Figure 2E), (IV) ubiquitin-related 
proteasomal degradation of RNAPII, which is the so-called ‘last resort’ mechanism (Figure 2F) 
[50,51]. CSB and TFIIH play a pivotal role in the displacement of RNAPII, although they have 
opposite effects according to the orientation of translocation: CSB and TFIIH possess forward and 
reverse translocase activities, respectively. At minor lesions, CSB contributes to the resumption of 
transcription elongation by pulling the DNA strand [52] (Figure 2A). However, at bulky lesions, the 
reverse translocase activity of TFIIH predominates [53] (Figure 2D).  
In the ‘last resort’ pathway, when RNAPII has to be completely removed from DNA, RPB1 (the 
largest subunit of RNAPII) is ubiquitylated by several E3-ligases. NEDD4 catalyzes K63-linked 
polyubiquitylation of RNAPII, of which the ubiquitin chain can be shortened by UBP2. Subsequently, 
the remaining monoubiquityl group is processed to K48-linked polyubiquityl chains by the Elongin 
A/B/C-Cul5-RBX2 complex, resulting in the proteasomal degradation of the S2P RNAPII. This step 
can be reversed by the contribution of UBP3 [6,7]. The chromatin remodeler INO80, the segregase 
VCP/p97, and its co-factors, UFD1 (Ubiquitin fusion degradation protein 1) and UBDXN7 are also 
involved in the degradation process [54] (Figure 2F). 
Following lesion removal, several factors mediate the resumption of transcription: (I) the FACT 
(Facilitates chromatin transcription) complex ensures the turnover of H2A and H2B from the 
damaged site, and therefore destabilizes the nucleosomes, (II) DOT1L (DOT1 like histone lysine 
methyltransferase) catalyzes the dimethylation of H3K79, hence accelerating the transcription 
process, (III) HIRA (Histone regulator A) facilitates the deposition of H3.3 at the lesions, and since 
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H3.3 is mainly present at transcriptionally active regions, the accumulation of this histone variant 
promotes the recovery of RNA synthesis [55–57]. Furthermore, when lesion removal has been 
completed, CAF1 (Chromatin Assembly Factor 1) and ASF1 (Anti-silencing Factor 1) recruit the H3.1 
histone variant to the DNA [58–60]. By reorganizing the chromatin structure, these factors strongly 
contribute to the proper restart of transcription. 
 
Figure 2. Transcription-coupled-nucleotide excision repair (A) Following UV damage, elongating 
RNAPII (S2P RNAPII) is stalled, then NAP1L1 (Nucleosome assembly protein 1-like 1) as well as 
NAP1L4 (Nucleosome assembly protein 1-like 4) bind to CSB (Cockayne syndrome B protein). This 
contributes to the unwinding of the DNA and the forward translocation of RNAPII (indicated with a 
dashed arrow). (B) CRL4CSA (composed of CUL4A, ROC1 - RING-box protein 1/RING subunit of SCF 
-, DDB1, and CSA - Cockayne syndrome A protein -) binds to and ubiquitylates CSB, taking part in 
the subsequent removal of CSB. CRL4CSA ubiquitylates RNAPII. Additionally, CSB can also be 
ubiquitylated by the BRCA1-BARD1 (Breast Cancer Type 1 Susceptibility Protein - BRCA1 Associated 
RING Domain 1) complex. In contrast, UVSSA (UV-stimulated scaffold protein A), by recruiting USP7 
DUB is involved in the deubiquitylation and subsequent stabilization of CSB. (C) Next, USP7 
dissociates from UVSSA allowing the binding of TFIIH (through its p62 subunit) to UVSSA. (D) 
Following the removal of USP7, CSB is ubiquitylated and degraded by the 26S proteasome. TFIIH is 
responsible for the reverse translocation of RNAPII (indicated with a dashed arrow). (E) Dissociation 
of RNAPII from DNA. (F) In the ubiquitin-related proteasomal degradation of RNAPII, NEDD4 
(Neural Precursor Cell Expressed, Developmentally Down-Regulated 4) (K63-linked) and the Elongin 
A/B/C-Cul5-RBX2 (RING-box protein 2) complex (K48-linked) are involved. UBP2 (Ubiquitin specific 
protease 2) participates in the deubiquitylation of K63-linked, while UBP3 (Ubiquitin specific protease 
3) takes part in the removal of K48-linked polyubiquitin chains from RNAPII. Additionally, the 
chromatin remodeler INO80, the segregase VCP/p97, and its co-factors, UFD1 (Ubiquitin fusion 
degradation protein 1) and UBDXN7, are also involved in the proteasomal degradation of RNAPII. 
2.3. DNA Damage Verification and Repair During NER 
Binding and subsequent removal of XPC and backtracking or displacement of RNAPII from the 
damaged site contribute to the recruitment of downstream factors in GG-NER and TC-NER, 
respectively. At this stage, the two sub-pathways merge and the subsequent steps will be common. 
First, TFIIH binds to the site of DNA damage, presumably with the contribution of the ATPase 
activity of XPB (Xeroderma pigmentosum, complementation group B) (encoded by ERCC3) 
strengthened by the TTDA (also known as GTF2H5) subunit of TFIIH [61] (Figure 3A). 
Simultaneously, the CAK (CDK-activating kinase) subcomplex dissociates from TFIIH [62]. XPB and 
XPD (Xeroderma pigmentosum, complementation group D) (encoded by ERCC2) promote the 
unwinding of the DNA strand around the lesion through their 3’-5’ and 5’-3’ helicase activity, 
respectively [63,64] (Figure 3A).  
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Next, XPA (Xeroderma pigmentosum, complementation group A) recognizes the damaged 
nucleotides and participates in the recruitment of further downstream repair factors to the DNA [65] 
(Figure 3A). However, XPA is tightly regulated by post-translational modifications. HERC2 (HECT 
Domain and RCC-Like Domain-Containing Protein 2)-mediated ubiquitylation of XPA can be 
attenuated through ATR (Ataxia Telangiectasia and RAD3-Related Protein)-mediated 
phosphorylation of XPA contributing to its stabilization [66]. Furthermore, PARylation of XPA 
impairs its DNA-binding affinity [67]. 
Following DNA unwinding, the single-strand DNA is coated and protected by RPA (Replication 
protein A), which help to position XPF-ERCC1 and XPG (encoded by ERCC5) endonucleases to the 
regions in the close vicinity of the lesion [68] (Figure 3A,B). XPF-ERCC1 heterodimer catalyzes the 5’ 
incision, while XPG is responsible for the 3’ incision of the lesion resulting in the removal of a 22-30 
nucleotide region [69,70]. ERCC1 is polyubiquitylated at its C-terminal (HhH)2 (double helix–
hairpin–helix) domain via K33 chains of ubiquitin through which it can heterodimerize with XPF 
[71,72]. However, XPF is not polyubiquitylated, and its protein level is significantly associated with 
that of ERCC1, suggesting that heterodimer formation is necessary for the stability of the complex 
[73,74]. USP45 (Ubiquitin specific peptidase 45) is essential for this process, because it participates in 
the removal of ubiquityl groups from ERCC1 [75] (Figure 3B).  
After the 5’ incision, PCNA (Proliferating cell nuclear antigen) is loaded onto the 5’ end of the 
DNA for gap filling through XPG [76] (Figure 3B). However, other evidence indicates that PCNA can 
be exclusively recruited when the damaged DNA region has been completely excised [77]. 
Furthermore, Cdt2 (Cell division cycle protein), one of the transiently bound subunits of the CRL4 
complex, is involved in the ubiquitylation-mediated degradation of XPG in the presence of PCNA 
[78] (Figure 3C). This step is important in facilitating further gap filling during DNA synthesis. DNA 
polymerases δ, ε and κ are responsible for DNA synthesis at the damaged strand using the 
undamaged strand as a template [79,80] (Figure 3D). Moreover, DNA polymerase δ can also serve as 
a substrate of the CRL4Cdt2 complex [81]. In the last step of NER, XRCC1-Ligase III mediates gap filling 
throughout the cell cycle, and Ligase I participates in this process during the S phase [82]. 
 
Figure 3 DNA damage verification and repair during NER (A) XPA (Xeroderma pigmentosum, 
complementation group A) recognizes modified nucleotides at the damaged strand and consequently 
facilitates the recruitment of TFIIH (including XPD (Xeroderma pigmentosum, complementation 
group D), XPB (Xeroderma pigmentosum, complementation group B), TTDA, and p62 subunits). 
Although the two helicase subunits of TFIIH, XPB and XPD, act as scaffold proteins during 
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transcription, both have functional importance in DNA unwinding in NER (indicated with dashed 
arrows) [63,83]. After the partial opening of the DNA helix, RPA (Replication protein A) joins the 
complex, which then contributes to damage verification. XPA preferably binds to kinked and 
branched dsDNA (double-strand DNA) structures than to single-stranded DNA, while RPA can be 
observed only at ssDNA (single-strand DNA) regions [84]. Moreover, in the pre-incision bubble, XPA 
has been shown to be located on the 5’-side of the lesion [85]. (B) XPF-ERCC1 (Xeroderma 
pigmentosum, complementation group F - Excision Repair Cross-Complementation Group 1) 
catalyzes the 5’ incision, while XPG (Xeroderma pigmentosum, complementation group G) is 
responsible for the 3’ incision around the lesion. ERCC1 is polyubiquitylated at K33, which can be 
removed by USP45 (Ubiquitin specific peptidase 45). PCNA (Proliferating cell nuclear antigen) is 
loaded onto the 5’ end of DNA. PCNA interacts with XPA and XPF, stimulating their activity [86,87]. 
(C) The lesion-containing 22-30 nucleotide DNA region is excised from the DNA in complex with 
TFIIH, which is then slowly released from TFIIH and becomes bound by RPA or degraded by 
nucleases [88]. During the incision steps, XPG is simultaneously ubiquitylated by CRL4Cdt2 and is then 
degraded in the 26S proteasome. (D) DNA synthesis is catalyzed by DNA polymerase δ/ε/κ.  
3. Precise Coordination of Ubiquitin-Mediated Removal of RNAPII upon Transcription Blockage 
Upon DNA damage, RNAPII becomes hyperphosphorylated to avoid initiation of a new 
transcription cycle until the damage sites are repaired [89]. As a ‘last resort’, when the damaged DNA 
cannot be repaired by TC-NER, S2P RNAPII has to be removed from the DNA through the ubiquitin-
proteasome system to allow access for the NER factors [8]. Ubiquitylation of S2P RNAPII can be 
initiated when TC-NER is activated after the blockage of transcription elongation [90] (Figure 2B). In 
mammalian cells, CSA, BRCA1-BARD1, and NEDD4 ubiquitin ligases are essential in the mono- or 
polyubiquitylation of S2P RNAPII. If transcription arrest cannot be resolved, S2P RNAPII is 
polyubiquitylated by the Elongin A/B/C-Cul5-RBX2 complex, but it can act only in the presence of 
NEDD4 [6,91] (Figure 2B,F). In yeast, UBP2 and UBP3 mediate the deubiquitylation of S2P RNAPII 
[6]. UBP2 can trim K63-linked, while UBP3 catalyzes the removal of K48-linked polyubiquitin chains 
from S2P RNAPII, which, in turn, leads to its monoubiquitylation [8] (Figure 2F). 
In case of serious DNA damage, several factors contribute to the blockage of transcription and 
the removal of S2P RNAPII from the damaged site. DNA-PK and WWP2 (WW domain containing 
E3 ubiquitin protein ligase 2) E3 ligase, which are involved in DSB repair, mediate transcription arrest 
upon DSB induction [92,93]. Following DNA-PK inhibition, S2P RNAPII can bypass the break site, 
suggesting that it is not the DNA-PK itself, but its activity, that is the key feature of this process [92]. 
Furthermore, one of the targets of DNA-PK, P53, interacts with RNAPII and might contribute to the 
removal of the S2P RNAPII upon Actinomycin D-induced transcription elongation blockage, and it 
facilitates the proteasome-mediated degradation of RNAPII at a transcribed unit [94]. 
The 26S proteasome can bind to actively transcribed gene regions at which RNAPII occupancy 
is high. This suggests that upon transcription arrest, the proteasome may degrade RNAPII at the site 
of damage [93,95]. As a first step of this process, the 19S subunit of the proteasome associates with 
RNAPII during transcription elongation. Upon transcription blockage, the 19S subunit, similar to a 
chaperone, takes part in the reassembly of the stalled transcription complex in a proteolysis-
independent manner, thereby promoting the resumption of transcription elongation [96,97]. In 
contrast, the 20S subunit is involved in the degradation of the terminally stalled RNAPII [96]. 
4. Concluding Remarks and Future Perspectives 
Preserving genome integrity is essential for normal cell physiology and is also necessary for 
maintaining the parental genetic information during replication. On the other hand, mutations in the 
genome can be beneficial for adaptation to environmental and evolutionary challenges. For this, 
dedicated balance is important during DNA repair. NER, which is specialized in repairing UV-
induced damage, is a tightly regulated process, in which PTMs, including ubiquitylation, play a 
pivotal role. The proper coordination of the repair mechanism and the maintenance of genome 
integrity are ensured by NER factors, including ubiquitin ligase complexes. 
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In GG-NER, the main ubiquitin ligase complex is CRL4DDB2, which has opposite effects on its 
targets, although both are polyubiquitylated through K48 chains: (I) catalyzing the ubiquitylation of 
DDB2 results in its proteasomal-dependent degradation, while (II) ubiquitylating XPC, one of the 
initial repair proteins bound to the UV-damaged sites, leads to its more tenacious DNA-binding. 
Interestingly, K48-linked polyubiquitylation does not result in the proteasomal degradation of XPC, 
which needs to be clarified in the future. Since neither the E2 ubiquitin-conjugating enzyme involved 
in this process nor the ubiquitylated amino acid residue has been identified, both may explain this 
phenomenon. In contrast, RNF111 is responsible for the K63-linked polyubiquitylation of XPC, 
resulting in its removal from the damaged DNA to allow access for further NER factors. Moreover, 
CRL4Cdt2 catalyzes the polyubiquitylation of XPG participating in the downstream incision steps.  
During TC-NER, the proper balance between CRL4CSA and UVSSA-USP7 has an indispensable 
effect on the access of downstream NER factors to the damaged region by mediating the ubiquitin-
proteasomal degradation of CSB, in which process the BRCA1-BARD1 complex is also implicated. 
As a result of serious DNA damage, the stalled RNAPII must be entirely removed from the damaged 
region with the contribution of several ubiquitin ligases, including NEDD4, BRCA1-BARD1, Elongin 
A/B/C-Cul5-RBX2, and WWP2. In certain cases, ubiquitylation-linked signalization is crucial, because 
NER factors cannot bind to the damaged sites without the removal of the stalled S2P RNAPII. 
In addition to ubiquitin ligases, DUBs also have a substantial function in the fine-tuning of NER. 
UBP12 and USP24 have been shown to contribute to the removal of K48-linked polyubiquitylation 
chains from DDB2 in fission yeast and in humans, respectively. USP51 is responsible for 
deubiquitylating the K13-15 residues of H2A, the exact role of which has not yet been clearly defined. 
XPC can be recycled by the removal of K48-linked polyubiquitin chains catalyzed by either USP7 or 
OTUD4. Furthermore, USP7 is essential for the ablation of K48-linked polyubiquitin chains from CSB. 
USP45 can remove the K33-linked polyubiquitin chains from ERCC1. In Saccharomyces cerevisiae, 
UBP2 and UBP3 are responsible for the removal of K63-linked and K48-linked polyubiquitin chains 
of RNAPII, respectively. Accordingly, DUBs can provide additional levels for the fine-tuning of DDR. 
Genes encoding DUB enzymes affected by mutations have recently been linked to various diseases, 
including cancer, and have been identified as promising drug targets for eliminating tumorous 
malformations. Unlike E3 ligases discussed in this review, DUBs are promising candidates for small-
molecule drug targets for developing novel cancer therapeutics. 
As discussed above, maintaining the proper balance between E3 ubiquitin ligases and DUBs is 
indispensable for the stringent coordination of NER pathways. In response to UV irradiation, the 
precise function of these factors ensures the preservation of genome integrity in a coordinated 
spatiotemporal manner, thereby significantly contributing to the prevention of cancerous 
malformations. We have already shown that SerpinB2 can play a role in the regulation of the NER 
pathway through the XPB protein as well as the ubiquitin network, and this function is altered in 
tumor cells [98]. Hence, being aware of any malfunction of even one of these factors can contribute 
to the better understanding the molecular background of the tumor. Consequently, applying either 
agonists or antagonists of the maleficent molecule can be beneficial in personalized tumor therapy. 
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